Back

Dynamic changes of cardiovascular biomarkers after ablation for atrial fibrillation: Observations from AXAFA-AFNET5.

28 August 2021 (20:42 - 20:51)
Organised by:
Congress Presentation Part of: Atrial fibrillation: the role of risk markers Rhythm Control, Catheter Ablation ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Winnie Chua

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Risk of atrial fibrillation in young adults aged 20 to 39 years with isolated diastolic, isolated systolic, and systolic-diastolic hypertension: a nationwide population-based study
Doctor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Clinical risk factors and P wave indices in prediction of atrial fibrillation development during long-term follow-up after acute ST-segment elevation myocardial infarction.
Doctor M. Baturova (Lund, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: the role of risk markers

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 20:42 CET
You may be interested in
thumbnail
Congress Presentation
Predictive value of biomarker dynamics for atrial fibrillation recurrence after pulmonary vein isolation: a prospective cohort study
30 March 2025
thumbnail
Congress Presentation
Cardiac biomarkers and cardiovascular side effects are associated with a reduced mortality of oncological patients receiving BRAF/MEK-Inhibitor therapy
21 June 2025
thumbnail
Congress Presentation
Biomarker BMP10 profiles suggest an association of female and age with atrial endomysial fibrosis: Results from the ISOLATION AF ablation registry
25 August 2023
thumbnail
Congress Presentation
Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources